| 12398187 |
CD19-directed chimeric antigen receptors and uses thereof in immunotherapy |
Luxuan Guo Buren, Chao Guo, Mira Tohmé, Ivan Ho Chan, Alexandra Leida Liana Lazetic |
2025-08-26 |
| 12351617 |
Immune cells comprising truncated NKG2D chimeric receptors |
Jun Hao Leong, Noriko Shimasaki, See Voon Seow, Dario Campana, Alexandra Leida Liana Lazetic +3 more |
2025-07-08 |
| 12012458 |
Genetically modified natural killer cells for CD70-directed cancer immunotherapy |
Alexandra Leida Liana Lazetic, Ivan Ho Chan, Chao Guo, Katherine Jamboretz |
2024-06-18 |
| 11970743 |
Gene expression markers for predicting overall survival in subjects treated with sipuleucel-T |
Nadeem Sheikh, Debraj GuhaThakurta, Harini Kandadi, Li Fan |
2024-04-30 |
| 11365236 |
Truncated NKG2D chimeric receptors and uses thereof in natural killer cell immunotherapy |
Jun Hao Leong, Noriko Shimasaki, See Voon Seow, Dario Campana, Alexandra Leida Liana Lazetic +3 more |
2022-06-21 |
| 11253547 |
CD19-directed chimeric antigen receptors and uses thereof in immunotherapy |
Luxuan Guo Buren, Chao Guo, Mira Tohmé, Ivan Ho Chan, Alexandra Leida Liana Lazetic |
2022-02-22 |
| 11154575 |
Cancer immunotherapy using CD19-directed chimeric antigen receptors |
Luxuan Guo Buren, Chao Guo, Mira Tohmé, Ivan Ho Chan, Alexandra Leida Liana Lazetic |
2021-10-26 |
| 11141436 |
Immune cells engineered to express CD19-directed chimeric antigen receptors and uses thereof in immunotherapy |
Luxuan Guo Buren, Chao Guo, Mira Tohmé, Ivan Ho Chan, Alexandra Leida Liana Lazetic |
2021-10-12 |
| 10261091 |
Humoral immune response against tumor antigens after treatment with a cancer antigen specific active immunotherapy and its association with improved clinical outcome |
Debraj GuhaThakurta, Nadeem Sheikh |
2019-04-16 |